This track focuses on the latest findings in Alzheimer's disease research, emphasizing novel therapeutic approaches and interventions. Participants will explore cutting-edge studies that highlight the role of biomarkers in early diagnosis and treatment efficacy.

This session will delve into the underlying biological mechanisms that contribute to neurodegenerative diseases. Discussions will include genetic, environmental, and lifestyle factors that influence disease progression.

This track aims to present recent advancements in the identification and validation of biomarkers for neurodegenerative diseases. Researchers will share insights on how these biomarkers can enhance diagnostic accuracy and patient stratification.

This session will explore the relationship between neuroinflammation and the progression of neurodegenerative disorders. Presentations will focus on the role of inflammatory pathways and potential therapeutic targets.

This track will investigate the correlation between cognitive decline and various neurodegenerative biomarkers. Researchers will present data on how these biomarkers can predict cognitive impairment and disease trajectory.

This session will highlight the role of advanced neuroimaging techniques in the discovery and validation of neurodegenerative biomarkers. Participants will discuss the integration of imaging data with clinical outcomes.